Martin Babler
2017
In 2017, Martin Babler earned a total compensation of $1.2M as President and Chief Executive Officer at Principia Biopharma.
Compensation breakdown
| Bonus | $229,075 |
|---|---|
| Option Awards | $590,258 |
| Salary | $374,000 |
| Other | $522 |
| Total | $1,193,855 |
Babler received $590.3K in option awards, accounting for 49% of the total pay in 2017.
Babler also received $229.1K in bonus, $374K in salary and $522 in other compensation.
Rankings
In 2017, Martin Babler's compensation ranked 8,124th out of 14,666 executives tracked by ExecPay. In other words, Babler earned more than 44.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,124 out of 14,666 | 45th |
Division Manufacturing | 3,066 out of 5,772 | 47th |
Major group Chemicals And Allied Products | 1,012 out of 2,075 | 51st |
Industry group Drugs | 795 out of 1,731 | 54th |
Industry Pharmaceutical Preparations | 625 out of 1,333 | 53rd |
Source: SEC filing on April 26, 2019.
Babler's colleagues
We found one more compensation record of an executive who worked with Martin Babler at Principia Biopharma in 2017.
2017
Stefani Wolff
Principia Biopharma